Coral Laboratories Limited (BOM:524506)
650.10
+1.35 (0.21%)
At close: Aug 21, 2026
Coral Laboratories Revenue
Coral Laboratories had revenue of 317.74M INR in the quarter ending June 30, 2026, with 68.82% growth. This brings the company's revenue in the last twelve months to 968.04M, down -5.25% year-over-year. In the fiscal year ending March 31, 2026, Coral Laboratories had annual revenue of 859.00M, down -25.31%.
Revenue (ttm)
968.04M
Revenue Growth
-5.25%
P/S Ratio
2.40
Revenue / Employee
4.91M
Employees
197
Market Cap
2.32B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 859.00M | -291.06M | -25.31% |
| Mar 31, 2025 | 1.15B | 313.45M | 37.47% |
| Mar 31, 2024 | 836.60M | 55.42M | 7.09% |
| Mar 31, 2023 | 781.19M | 25.08M | 3.32% |
| Mar 31, 2022 | 756.11M | -209.57M | -21.70% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.69B |
| Sat Kartar Life | 2.01B |
| Everest Organics | 1.92B |
| Gennex Laboratories | 1.78B |
| Astonea Labs | 1.48B |
| Kerala Ayurveda | 1.36B |
| Oxygenta Pharmaceutical | 1.35B |
| BDH Industries | 997.10M |